Tarsus Pharmaceuticals Inc (TARS)
46.65
+0.15
(+0.32%)
USD |
NASDAQ |
Nov 14, 16:00
46.49
-0.16
(-0.34%)
After-Hours: 16:50
Tarsus Pharmaceuticals Total Assets (Quarterly): 376.84M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 376.84M |
| March 31, 2024 | 349.28M |
| December 31, 2023 | 265.49M |
| September 30, 2023 | 268.33M |
| June 30, 2023 | 188.93M |
| March 31, 2023 | 211.21M |
| December 31, 2022 | 227.86M |
| September 30, 2022 | 236.46M |
| June 30, 2022 | 252.83M |
| Date | Value |
|---|---|
| March 31, 2022 | 181.48M |
| December 31, 2021 | 178.91M |
| September 30, 2021 | 190.41M |
| June 30, 2021 | 203.45M |
| March 31, 2021 | 193.95M |
| December 31, 2020 | 171.97M |
| September 30, 2020 | 92.18M |
| June 30, 2020 | 56.24M |
| December 31, 2019 | 58.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
56.24M
Minimum
Jun 2020
376.84M
Maximum
Jun 2024
205.79M
Average
198.70M
Median
Total Assets (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 786.56M |
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
| NovaBay Pharmaceuticals Inc | 3.925M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 124.60M |
| Shareholders Equity (Quarterly) | 252.25M |
| Debt to Equity Ratio | 0.2838 |
| Current Ratio | 7.031 |
| Net Debt Paydown Yield | -0.91% |